{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:15:23Z","timestamp":1780463723615,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02732-8","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T14:18:09Z","timestamp":1745849889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Detection of Immunoglobulin G and\/or IgM antibodies specific for Lassa virus among HIV patients in the Northwestern region of Cameroon"],"prefix":"10.1186","volume":"22","author":[{"given":"Lem Edith","family":"Abongwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Njefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ntonifor Helen","family":"Ngum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teboh","family":"Rogeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluremi Israel","family":"Ajayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerades Dely","family":"Djoufack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philomena","family":"Eromon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinedu","family":"Ugwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onikepe","family":"Folarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Happi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"issue":"1","key":"2732_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-7-279","volume":"7","author":"LM Branco","year":"2010","unstructured":"Branco LM, Grove JN, Geske FJ, Boisen ML, Muncy IJ, Magliato SA, Henderson LA, Schoepp RJ, Cashman KA, Hensley LE, Garry RF. Lassa virus-like particles display all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever. Virol J. 2010;7(1):1\u20139.","journal-title":"Virol J"},{"issue":"1","key":"2732_CR2","doi-asserted-by":"publisher","first-page":"8724","DOI":"10.1038\/s41598-020-65736-0","volume":"10","author":"ML Boisen","year":"2020","unstructured":"Boisen ML, Uyigue E, Aiyepada J, Siddle KJ, Oestereich L, Nelson DK, Bush DJ, Rowland MM, Heinrich ML, Eromon P, Kayode AT. Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak. Sci Rep. 2020;10(1):8724.","journal-title":"Sci Rep"},{"issue":"1","key":"2732_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41541-018-0049-5","volume":"3","author":"HJ Hallam","year":"2018","unstructured":"Hallam HJ, Hallam S, Rodriguez SE, Barrett AD, Beasley DW, Chua A, Ksiazek TG, Milligan GN, Sathiyamoorthy V, Reece LM. Baseline mapping of Lassa fever virology, epidemiology, and vaccine research and development. NPJ Vaccines. 2018;3(1):11.","journal-title":"NPJ Vaccines"},{"issue":"1","key":"2732_CR4","doi-asserted-by":"publisher","first-page":"16030","DOI":"10.1038\/s41598-020-72539-w","volume":"10","author":"ML Heinrich","year":"2020","unstructured":"Heinrich ML, Boisen ML, Nelson DK, Bush DJ, Cross RW, Koval AP, Hoffmann AR, Beddingfield BJ, Hastie KM, Rowland MM, Aimukanova I. Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with Recombinant proteins representing Lassa viruses of divergent lineages. Sci Rep. 2020;10(1):16030.","journal-title":"Sci Rep"},{"issue":"4","key":"2732_CR5","doi-asserted-by":"publisher","first-page":"e00366","DOI":"10.1128\/spectrum.00366-22","volume":"10","author":"AN Happi","year":"2022","unstructured":"Happi AN, Olumade TJ, Ogunsanya OA, Sijuwola AE, Ogunleye SC, Oguzie JU, Nwofoke C, Ugwu CA, Okoro SJ, Otuh PI, Ngele LN. Increased prevalence of Lassa fever virus-positive rodents and diversity of infected species found during human Lassa fever epidemics in Nigeria. Microbiol Spectr. 2022;10(4):e00366\u201322.","journal-title":"Microbiol Spectr"},{"issue":"2","key":"2732_CR6","first-page":"1","volume":"3","author":"OJ Adenola","year":"2020","unstructured":"Adenola OJ, Ilemobayo AM. Lassa fever in Nigeria. Asian J Res Rep Gastroenterol. 2020;3(2):1\u20138.","journal-title":"Asian J Res Rep Gastroenterol"},{"key":"2732_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijid.2022.04.004","volume":"119","author":"V Raabe","year":"2022","unstructured":"Raabe V, Mehta AK, Evans JD, Beitscher A, Bhadelia N, Brett-Major D, Cieslak TJ, Davey RT, Evans JD, Frank MG, Iwen P. Lassa virus infection: a summary for clinicians. Int J Infect Dis. 2022;119:187\u2013200.","journal-title":"Int J Infect Dis"},{"issue":"9","key":"2732_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/14787210.2018.1512856","volume":"16","author":"GO Akpede","year":"2018","unstructured":"Akpede GO, Asogun DA, Okogbenin SA, Okokhere PO. Lassa fever outbreaks in Nigeria. Expert Rev anti-infective Therapy. 2018;16(9):663\u20136.","journal-title":"Expert Rev anti-infective Therapy"},{"issue":"1","key":"2732_CR9","doi-asserted-by":"publisher","first-page":"22330","DOI":"10.1038\/s41598-022-26045-w","volume":"12","author":"C Ugwu","year":"2022","unstructured":"Ugwu C, Olumade T, Nwakpakpa E, Onyia V, Odeh E, Duruiheoma RO, Ojide CK, Eke MA, Nwafor IE, Chika-Igwenyi N, Abu AM. Humoral and cellular immune responses to Lassa fever virus in Lassa fever survivors and their exposed contacts in Southern Nigeria. Sci Rep. 2022;12(1):22330.","journal-title":"Sci Rep"},{"issue":"11","key":"2732_CR10","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1128\/JCM.36.11.3143-3148.1998","volume":"36","author":"J Ter Meulen","year":"1998","unstructured":"Yaro CA, Kogi E, Opara KN, Batiha GE, Baty RS, Albrakati A, Altalbawy FM, Etuh IU, Oni JP. Infection pattern, case fatality rate and spreadof Lassa virus in Nigeria. BMC Infectious Diseases. 2021;21:1-9.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"2732_CR11","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1128\/JCM.38.7.2670-2677.2000","volume":"38","author":"DG Bausch","year":"2000","unstructured":"Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, Conteh AS, Wagoner KD, McMullan LK, Bowen MD, Peters CJ, Ksiazek TG. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol. 2000;38(7):2670\u20137.","journal-title":"J Clin Microbiol"},{"issue":"05","key":"2732_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.47772\/IJRISS.2021.5526","volume":"5","author":"A Abdullahi","year":"2021","unstructured":"Abdullahi A, Gawi YA. The effects of border porosity on Nigeria\u2019s National security: A study of Nigeria\u2019s Northeastern border to Cameroon. Int J Res Innov Social Sci. 2021;5(05):442\u201350.","journal-title":"Int J Res Innov Social Sci"},{"key":"2732_CR13","doi-asserted-by":"crossref","unstructured":"Akowuah KA, Ofori MS, Pratt D, Abankwa A, Bonney EY, Enimil N, et al. The epidemiology of lassa fever in Ghana: A study on the 2023 lassa fever outbreak. Front Public Health. 2025;13:1542842.","DOI":"10.3389\/fpubh.2025.1542842"},{"issue":"4","key":"2732_CR14","doi-asserted-by":"publisher","first-page":"e0283991","DOI":"10.1371\/journal.pone.0283991","volume":"18","author":"A Buh","year":"2023","unstructured":"Buh A, Deonandan R, Gomes J, Krentel A, Oladimeji O, Yaya S. Prevalence and factors associated with HIV treatment non-adherence among people living with HIV in three regions of Cameroon: A cross-sectional study. PLoS ONE. 2023;18(4):e0283991. https:\/\/doi.org\/10.1371\/journal.pone.0283991. PMID: 37014900; PMCID: PMC10072448.","journal-title":"PLoS ONE"},{"key":"2732_CR15","unstructured":"UNAIDS. Country factsheets: Cameroon\u20142021 [Internet]. [Accessed 2025 Mar 19]. Available from: https:\/\/www.unaids.org\/en\/regionscountries\/countries\/cameroon"},{"issue":"5","key":"2732_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1086\/367655","volume":"36","author":"CB Holmes","year":"2003","unstructured":"Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA. Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clin Infect Dis. 2003;36(5):652\u201362.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2732_CR17","doi-asserted-by":"publisher","first-page":"824","DOI":"10.18203\/2394-6040.ijcmph20230246","volume":"10","author":"OP Olanrewaju","year":"2023","unstructured":"Olanrewaju OP, Omosalewa OE, Okoro L, Olawale OR. Co-epidemics: implications of COVID-19 outbreak associated with human immune-deficiency virus, tuberculosis and Lassa fever in a low resource economy-a call for proactive measures. Int J Community Med Public Health. 2023;10(2):824.","journal-title":"Int J Community Med Public Health"},{"issue":"8","key":"2732_CR18","first-page":"1","volume":"2","author":"C Abejegah","year":"2021","unstructured":"Abejegah C, Owhin SO, Abiodun AT, Adeniyi BO. Lassa fever coinfection with COVID-19 among health care workers: report of two cases. Annals Med Res Pract. 2021;2(8):1.","journal-title":"Annals Med Res Pract"},{"key":"2732_CR19","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1097\/QAD.0000000000001441","volume":"31","author":"C Lagathu","year":"2017","unstructured":"Lagathu C, Cossarizza A, B\u00e9r\u00e9ziat V, Nasi M, Capeau J, Pinti M. Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers. Aids. 2017;31:S105\u201319.","journal-title":"Aids"},{"issue":"12","key":"2732_CR20","doi-asserted-by":"publisher","first-page":"e0279467","DOI":"10.1371\/journal.pone.0279467","volume":"17","author":"MM Dalhat","year":"2022","unstructured":"Dalhat MM, Olayinka A, Meremikwu MM, Dan-Nwafor C, Iniobong A, Ntoimo LF, Onoh I, Mba S, Ohonsi C, Arinze C, Esu EB. Epidemiological trends of Lassa fever in Nigeria, 2018\u20132021. PLoS ONE. 2022;17(12):e0279467.","journal-title":"PLoS ONE"},{"key":"2732_CR21","unstructured":"http:\/\/www.zalgenlabs.com\/hemorrhagic-fever-tests-list-2.html Accessed on March 23rd 2023."},{"key":"2732_CR22","unstructured":"https:\/\/iris.who.int\/bitstream\/handle\/10665\/360860\/9789240055179-eng.pdf Accessed on March 3rd 2025."},{"key":"2732_CR23","doi-asserted-by":"crossref","unstructured":"Mofolorunsho KC. The outbreak of Lassa fever in Nigeria: measures for prevention and control. Pan Afr Med J. 2016;23(1).","DOI":"10.11604\/pamj.2016.23.210.8923"},{"issue":"4","key":"2732_CR24","first-page":"679","volume":"81","author":"P Paix","year":"1988","unstructured":"Paix P MA, Poveda P JD, Malvy D, Bailly C, Merlin M, Fleury HJ. Serological study of the virus responsible for hemorrhagic fever in an urban population of Cameroon. Bull De La Societe De Pathologie Exotique Et De Ses Filiales. 1988;81(4):679\u201382.","journal-title":"Bull De La Societe De Pathologie Exotique Et De Ses Filiales"},{"issue":"4","key":"2732_CR25","first-page":"631","volume":"57","author":"H Wulff","year":"1979","unstructured":"Wulff H, Johnson KM. Immunoglobulin M and G responses measured by Immunofluorescence in patients with Lassa or Marburg virus infections. Bull World Health Organ. 1979;57(4):631.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"2732_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4269\/ajtmh.2012.12-0466","volume":"88","author":"N Bond","year":"2013","unstructured":"Bond N, Schieffelin JS, Moses LM, Bennett AJ, Bausch DG. A historical look at the first reported cases of Lassa fever: IgG antibodies 40 years after acute infection. Am J Trop Med Hyg. 2013;88(2):241\u20134. https:\/\/doi.org\/10.4269\/ajtmh.2012.12-0466. PMID: 23390223; PMCID: PMC3583312.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"2732_CR27","first-page":"125","volume":"9","author":"BN Ogunro","year":"2019","unstructured":"Ogunro BN, Olugasa BO, Kayode A, Ishola OO, Kolawole ON, Odigie EA, Happi C. Detection of antibody and antigen for Lassa virus nucleoprotein in monkeys from Southern Nigeria. J Epidemiol Global Health. 2019;9(2):125.","journal-title":"J Epidemiol Global Health"},{"issue":"2","key":"2732_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1128\/jcm.20.2.239-244.1984","volume":"20","author":"BS Niklasson","year":"1984","unstructured":"Niklasson BS, Jahrling PB, Peters CJ. Detection of Lassa virus antigens and Lassa virus-specific Immunoglobulins G and M by enzyme-linked immunosorbent assay. J Clin Microbiol. 1984;20(2):239\u201344.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2732_CR29","doi-asserted-by":"publisher","first-page":"152076","DOI":"10.1016\/j.imbio.2021.152076","volume":"226","author":"JO Shaibu","year":"2021","unstructured":"Shaibu JO, Salu OB, Amoo OS, Idigbe I, Musa AZ, Ezechi OC, Abejegah C, Ayodeji O, Salako BL, Omilabu SA, Audu RA. Immunological screening of Lassa virus among health workers and contacts of patients of Lassa fever in Ondo state. Immunobiology. 2021;226(3):152076.","journal-title":"Immunobiology"},{"key":"2732_CR30","unstructured":"WHO fact sheet on Lassa fever https:\/\/www.afro.who.int\/health-topics\/lassa-fever\/outbreak\/1-march-2018-nigeria"},{"issue":"12","key":"2732_CR31","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1093\/infdis\/jix206","volume":"215","author":"WA Fischer","year":"2017","unstructured":"Fischer WA 2nd, Wohl DA. Moving Lassa fever research and care into the 21st century. J Infect Dis. 2017;215(12):1779\u201381. PMID: 28863471; PMCID: PMC5853919. https:\/\/doi.org\/10.1093\/infdis\/jix206","journal-title":"J Infect Dis"},{"key":"2732_CR32","doi-asserted-by":"crossref","unstructured":"Nwafor IE, Ogah OE, Ojide CK, Odeh EC, Abu AM, Chika-Igwenyi NM, Nwidi DU, Unigwe US, Ajayi NA, Eke MA, Obasi MN. Prevalence and outcome of Lassa fever among hospitalized patients in Ebonyi State, Nigeria, 2018\u20132019. Virus research. 2020; 285: 198000.","DOI":"10.1016\/j.virusres.2020.198000"},{"key":"2732_CR33","doi-asserted-by":"publisher","unstructured":"Murphy H, Ly H. Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines. Vaccines (Basel). 2022;10(10):1668. doi: 10.3390\/vaccines10101668. Erratum in: Vaccines (Basel). 2024;12(8):909. https:\/\/doi.org\/10.3390\/vaccines12080909. PMID: 36298533; PMCID: PMC9612042.","DOI":"10.3390\/vaccines12080909"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02732-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02732-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02732-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T14:18:23Z","timestamp":1745849903000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02732-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2732"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02732-8","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out following the relevant guidelines and regulations, including the Declaration of Helsinki. The study protocol was approved by the Research and Ethical Review Committee\/Institutional Review Board of the University of Bamenda (2020\/0244H\/UBa\/IRB). The study procedures were performed in accordance with the applicable guidelines. All the participants were given an oral explanation of the purpose and content of the study. Written informed consent was obtained from the participants or parents\/guardians of the children 18 years and younger who were involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. All the material and figures in the article were collected, analysed, and prepared by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}